Why is monitoring CO2 (carbon dioxide) levels important in a patient with euglycemic diabetic ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why CO2 Monitoring Matters in Euglycemic DKA

Monitoring CO2 levels in euglycemic DKA is critical because bicarbonate and CO2 are your primary indicators of acidosis severity and treatment response when glucose cannot serve as a reliable marker—and in euglycemic DKA, glucose levels remain deceptively normal (<250 mg/dL) despite ongoing life-threatening ketoacidosis. 1, 2

The Core Problem: Glucose Misleads You

In classic DKA, you track three parameters simultaneously: glucose, pH/bicarbonate, and ketones. In euglycemic DKA, glucose fails as a severity marker because it stays below 250 mg/dL throughout the crisis. 1, 2 This leaves you dependent on acid-base parameters—specifically CO2 (or bicarbonate, which directly correlates)—to determine:

  • Whether DKA exists at all: Serum bicarbonate must be <15 mEq/L (corresponding to low CO2) to meet diagnostic criteria, even when glucose is normal 1, 2
  • How severe the DKA is: CO2/bicarbonate stratifies severity (mild: bicarbonate 15-18 mEq/L; moderate: 10-15 mEq/L; severe: <10 mEq/L) 1, 2
  • Whether treatment is working: Resolution requires bicarbonate ≥18 mEq/L and venous pH >7.3, not glucose normalization 1, 3

Why Euglycemic DKA Happens and Why It's Dangerous

Euglycemic DKA occurs increasingly with SGLT2 inhibitors (which cause urinary glucose loss), ketogenic diets, pregnancy, reduced caloric intake, or insulin pump failure with some residual insulin effect. 4, 2 The danger is that clinicians may dismiss the diagnosis when they see "normal" glucose, delaying recognition of severe acidosis. 2

The Monitoring Algorithm for Euglycemic DKA

Initial Assessment

  • Check venous pH, serum bicarbonate (or CO2), and blood β-hydroxybutyrate immediately alongside glucose 1, 2
  • Calculate anion gap: [Na⁺] - ([Cl⁻] + [HCO₃⁻]); should be >10-12 mEq/L in DKA 1, 2
  • Diagnose euglycemic DKA when: glucose <250 mg/dL BUT pH <7.3, bicarbonate <15 mEq/L, and elevated β-hydroxybutyrate 1, 2

During Treatment

  • Monitor CO2/bicarbonate every 2-4 hours along with electrolytes, pH, and β-hydroxybutyrate 1, 3
  • Start dextrose 5% immediately with 0.9% saline when beginning insulin treatment in euglycemic DKA (unlike classic DKA where you wait until glucose falls to 250 mg/dL) 3
  • Continue insulin infusion until bicarbonate ≥18 mEq/L and pH >7.3, regardless of glucose levels 3

Resolution Criteria

DKA is resolved only when ALL of the following are met: glucose <200 mg/dL, bicarbonate ≥18 mEq/L, venous pH >7.3, and anion gap ≤12 mEq/L. 1, 3 In euglycemic DKA, the glucose criterion is already met, making CO2/bicarbonate your sole metabolic endpoint.

Critical Pitfalls to Avoid

Never stop insulin when glucose normalizes in euglycemic DKA—ketoacidosis takes longer to clear than hyperglycemia, and premature insulin cessation causes recurrent ketoacidosis. 4, 3 The bicarbonate/CO2 must normalize first. 3

Don't rely on urine ketones—they measure acetoacetate, not β-hydroxybutyrate (the predominant ketoacid), and paradoxically worsen as treatment succeeds. 1, 3 Use blood β-hydroxybutyrate instead. 1, 2

Venous pH suffices after initial diagnosis—avoid repeated arterial sticks, as venous pH tracks acidosis resolution adequately (typically 0.03 units lower than arterial). 1, 3

Why CO2 Correlates with Clinical Severity

CO2 levels reflect respiratory compensation for metabolic acidosis. 5, 6 Low CO2 (<18 mmol/L on basic metabolic panel) indicates the body is hyperventilating to blow off CO2 and partially compensate for the acidosis. 7, 6 End-tidal CO2 monitoring shows strong correlation with arterial CO2 and bicarbonate (ETCO2 >24.5 mmHg rules out DKA with 90% sensitivity/specificity), making it a useful noninvasive adjunct. 8, 6 In severe DKA, profound hypocapnia from compensatory hyperventilation can complicate mechanical ventilation if needed. 9

The Bottom Line for Euglycemic DKA

In euglycemic DKA, CO2/bicarbonate becomes your primary treatment target because glucose cannot guide you. 1, 2, 3 You must add dextrose from the start, continue insulin until acid-base parameters normalize (not glucose), and monitor CO2/bicarbonate every 2-4 hours to track resolution. 3 Missing this distinction leads to premature insulin discontinuation and recurrent ketoacidosis. 4, 3

References

Guideline

Diagnostic Criteria and Management of Diabetic Ketoacidosis (DKA)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Approach to Diabetic Ketoacidosis (DKA)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Resolving Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Respiratory failure in diabetic ketoacidosis.

World journal of diabetes, 2015

Research

Point-of-care test identifies diabetic ketoacidosis at triage.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2006

Research

Unknown Use of End-tidal CO2 in Metabolic Emergencies in Pediatric Patients.

Journal of translational internal medicine, 2019

Research

Hyperventilation in severe diabetic ketoacidosis.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.